banner
RNA-DNA polymerase inhibitor, BMH-21, Purity ≥98%
Inquiry

Cat. No.: X24-08-YM132

RNA-DNA polymerase inhibitor, BMH-21, Purity ≥98%

Synonym: 896705-16-1; BMH21; BMH 21; N-[2-(Dimethylamino)ethyl]-12-oxo-12H-benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide

  • MDL: MFCD27225377
  • CAS Number: 896705-16-1
  • Compound CID: 3508054
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
BMH-21, soluble in warmed DMSO and warmed ethanol and insoluble in water, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting RNA-DNA polymerase.
Molecular Weight
360.4
Molecular Formula
C21H20N4O2
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO (warmed): 4 mg/mL (11.1 mM); Water: insoluble; Ethanol (warmed): 2 mg/mL (5.54 mM)
Applications
BMH-21 is a DNA damage inhibitor that plays a key role in targeting transcription-related processes involved in tumor growth and resistance.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0